- Home
- QSI vs AGL Comparison
QSI vs AGL Comparison
Compare QSI & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | AGL |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 270.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | QSI | AGL |
|---|---|---|
| Price | $1.26 | $0.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 18 |
| Target Price | ★ $2.88 | $2.79 |
| AVG Volume (30 Days) | 4.2M | ★ 10.2M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,177,000.00 | ★ $5,885,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $159.68 | $3.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 40.20 | 5.21 |
| 52 Week Low | $0.95 | $0.51 |
| 52 Week High | $5.77 | $6.08 |
Technical Indicators
Market Signals| Indicator | QSI | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 54.17 |
| Support Level | $1.18 | $0.65 |
| Resistance Level | $1.31 | $0.74 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 20.83 | 85.13 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.